Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HiFi DNA Tech is a molecular diagnostics company specializing in high-sensitivity DNA sequencing-based testing for infectious diseases. Founded by Dr. Sin Hang Lee, the company utilizes a proprietary nested PCR and automated Sanger sequencing platform to provide definitive identification of pathogens. Key focus areas include Human Papillomavirus (HPV) and Borrelia burgdorferi, the causative agent of Lyme disease. Their technology is designed to reduce false positives and negatives common in traditional serological or standard PCR tests by providing direct sequence evidence. The company provides both diagnostic kits and laboratory services to clinical and research partners. Its approach is often cited as a "gold standard" for diagnostic accuracy in complex clinical cases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HiFi DNA Tech.